Literature DB >> 15670024

Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study.

B Brenner1, R Hoffman, H Carp, M Dulitsky, J Younis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15670024     DOI： 10.1111/j.1538-7836.2004.01090.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  18 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.

Authors:  Paulien G de Jong; Stef Kaandorp; Marcello Di Nisio; Mariëtte Goddijn; Saskia Middeldorp
Journal:  Cochrane Database Syst Rev       Date:  2014-07-04

3.  Safety and efficacy of low molecular weight heparin therapy during pregnancy: three year experience at a tertiary care center.

Authors:  Nilanchali Singh; Priya Varshney; Reva Tripathi; Y M Mala; Shakun Tyagi
Journal:  J Obstet Gynaecol India       Date:  2013-06-12

4.  Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).

Authors:  B Toth; W Würfel; M K Bohlmann; G Gillessen-Kaesbach; F Nawroth; N Rogenhofer; C Tempfer; T Wischmann; M von Wolff
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-11       Impact factor: 2.915

Review 5.  Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.

Authors:  Rebecca Tooher; Simon Gates; Therese Dowswell; Lucy-Jane Davis
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

6.  Heparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model.

Authors:  Jianzhong An; Magarya S Waitara; Michelle Bordas; Vidhyalakshmi Arumugam; Raymond G Hoffmann; Brian G Petrich; Uma Sinha; Paula E North; Rashmi Sood
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

7.  Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy.

Authors:  Esme V Menezes; Mohammad Yawar Yakoob; Tanya Soomro; Rachel A Haws; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

Review 8.  Thrombophilia and Recurrent Pregnancy Loss: Is heparin still the drug of choice?

Authors:  Adel Abu-Heija
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

9.  Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol.

Authors:  Pablo Alonso-Coello; Shanil Ebrahim; Gordon H Guyatt; Kari A O Tikkinen; Mark H Eckman; Ignacio Neumann; Sarah D McDonald; Elie A Akl; Shannon M Bates
Journal:  BMC Pregnancy Childbirth       Date:  2012-05-30       Impact factor: 3.007

10.  Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy.

Authors:  Maristella D'Uva; Pierpaolo Di Micco; Ida Strina; Antonio Ranieri; Carlo Alviggi; Antonio Mollo; Francesca Fabozzi; Lucia Cacciapuoti; Maria Teresa Scotto di Frega; Mariateresa Iannuzzo; Giuseppe De Placido
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.